cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.6084/m9.figshare.5801871.v1
title: Additional file 5; Table S5. of Radiation-induced pulmonary gene expression changes are attenuated by the CTGF antibody Pamrevlumab

description: GO categories associated with the RT-diminished gene set. (XLSX 12Â kb)
DOI: 10.6084/m9.figshare.5801868
title: Additional file 1 of OpenBiodiv-O: ontology of the OpenBiodiv knowledge management system

description: Ontology is a plain text file containing statements in the Turtle syntax forming OpenBiodiv-O. It can be edited in a text (e.g. Sublime Text, Emacs, etc.) or in an ontology editor (e.g. ProtĂŠgĂŠ). It can be loaded it into a triple store (e.g. GraphDB). The prefixes that are used throughout this manuscript are defined at the beginning. This file corresponds to &lt; http://openbiodiv.net/openbiodivo-20171103 &gt;. (TXT 22 kb)
DOI: 10.6084/m9.figshare.5801868.v1
title: Additional file 1 of OpenBiodiv-O: ontology of the OpenBiodiv knowledge management system

description: Ontology is a plain text file containing statements in the Turtle syntax forming OpenBiodiv-O. It can be edited in a text (e.g. Sublime Text, Emacs, etc.) or in an ontology editor (e.g. ProtĂŠgĂŠ). It can be loaded it into a triple store (e.g. GraphDB). The prefixes that are used throughout this manuscript are defined at the beginning. This file corresponds to &lt; http://openbiodiv.net/openbiodivo-20171103 &gt;. (TXT 22 kb)
DOI: 10.6084/m9.figshare.5801853
title: Additional file 4: Table S4. of Radiation-induced pulmonary gene expression changes are attenuated by the CTGF antibody Pamrevlumab

description: GO categories associated with the RT-elevated gene set. (XLSX 24Â kb)
DOI: 10.6084/m9.figshare.5801853.v1
title: Additional file 4: Table S4. of Radiation-induced pulmonary gene expression changes are attenuated by the CTGF antibody Pamrevlumab

description: GO categories associated with the RT-elevated gene set. (XLSX 24Â kb)
DOI: 10.6084/m9.figshare.5801835
title: Additional file 3: Table S3. of Radiation-induced pulmonary gene expression changes are attenuated by the CTGF antibody Pamrevlumab

description: Radiation and FG-3019 Responsive Genes (nâ =â 2754). (XLSX 674Â kb)
DOI: 10.6084/m9.figshare.5801835.v1
title: Additional file 3: Table S3. of Radiation-induced pulmonary gene expression changes are attenuated by the CTGF antibody Pamrevlumab

description: Radiation and FG-3019 Responsive Genes (nâ =â 2754). (XLSX 674Â kb)
DOI: 10.6084/m9.figshare.5801817
title: Additional file 2: Table S2. of Radiation-induced pulmonary gene expression changes are attenuated by the CTGF antibody Pamrevlumab

description: Cell-Type Distinguishing Gene Lists. (XLSX 59Â kb)
DOI: 10.6084/m9.figshare.5801817.v1
title: Additional file 2: Table S2. of Radiation-induced pulmonary gene expression changes are attenuated by the CTGF antibody Pamrevlumab

description: Cell-Type Distinguishing Gene Lists. (XLSX 59Â kb)
DOI: 10.6084/m9.figshare.5801799
title: Additional file 2: Table S2. of Chromothripsis 18 in multiple myeloma patient with rapid extramedullary relapse

description: Annotation table of 338 called SNP variants from 62 leukemia-associated genes detected NGS Leukemia panel from Sistema Genómicos. (XLSX 91 kb)
DOI: 10.6084/m9.figshare.5801799.v1
title: Additional file 2: Table S2. of Chromothripsis 18 in multiple myeloma patient with rapid extramedullary relapse

description: Annotation table of 338 called SNP variants from 62 leukemia-associated genes detected NGS Leukemia panel from Sistema Genómicos. (XLSX 91 kb)
DOI: 10.6084/m9.figshare.5801793
title: Additional file 1: Table S1. of Radiation-induced pulmonary gene expression changes are attenuated by the CTGF antibody Pamrevlumab

description: Array Files used to Assemble a Human Cell-Type Expression Atlas and Normailzed CTGF Expression. (XLSX 20Â kb)
DOI: 10.6084/m9.figshare.5801793.v1
title: Additional file 1: Table S1. of Radiation-induced pulmonary gene expression changes are attenuated by the CTGF antibody Pamrevlumab

description: Array Files used to Assemble a Human Cell-Type Expression Atlas and Normailzed CTGF Expression. (XLSX 20Â kb)
DOI: 10.6084/m9.figshare.5801787
title: Additional file 1: Table S1. of Chromothripsis 18 in multiple myeloma patient with rapid extramedullary relapse

description: Aberration list for CNAs detected by array-CGH in MM patient with chromothripsis 18. Output from Agilent Genomic Workbench 7.0.4.0. (XLSX 13 kb)
DOI: 10.6084/m9.figshare.5801787.v1
title: Additional file 1: Table S1. of Chromothripsis 18 in multiple myeloma patient with rapid extramedullary relapse

description: Aberration list for CNAs detected by array-CGH in MM patient with chromothripsis 18. Output from Agilent Genomic Workbench 7.0.4.0. (XLSX 13 kb)
DOI: 10.6084/m9.figshare.5801784
title: MOESM1 of 3D-QSAR study of steroidal and azaheterocyclic human aromatase inhibitors using quantitative profile of protein–ligand interactions

description: Additional file 1 Dataset for model development.
DOI: 10.6084/m9.figshare.5801784.v1
title: MOESM1 of 3D-QSAR study of steroidal and azaheterocyclic human aromatase inhibitors using quantitative profile of protein–ligand interactions

description: Additional file 1 Dataset for model development.
DOI: 10.6084/m9.figshare.5801643
title: Regulation of eye and jaw colouration in three-spined stickleback (Gasterosteus aculeatus)

description: Fish can change their skin and eye colour for background matching and signalling. Males of Gasterosteus aculeatus develop ornamental blue eyes and a red jaw during the reproductive season, colours that are further enhanced during courtship. Here, we investigated the effects of different hormones on physiological colour changes in the eyes and jaws of male and female sticklebacks in vitro. In an in vivo experiment, sticklebacks were injected with a receptor blocker of a pivotal hormone that controls colour change. We found in males that noradrenaline had aggregating effects on melanophore and erythrophore pigments resulting in blue eyes and a pale jaw, whereas melanocyte-concentrating hormone (MCH) and melatonin resulted in a pale jaw only. When noradrenalin was combined with melanocyte stimulating hormone (MSH) or prolactin, the jaw became red, while the eyes remained blue. In vivo injection of yohimbine, an alpha-2 adrenoreceptor blocker, resulted in dispersion of melanophore pigment in the eyes and inhibited the blue colouration. Altogether, the data suggest that noradrenalin has a pivotal role in the short-term enhancement of the ornamental colouration of male sticklebacks, potentially together with MSH or prolactin. Interestingly, we also found a sex difference in the response to MCH, prolactin and melatonin, which may result from different appearance strategies in males, versus the more cryptic females.
DOI: 10.6084/m9.figshare.5801643.v1
title: Regulation of eye and jaw colouration in three-spined stickleback (Gasterosteus aculeatus)

description: Fish can change their skin and eye colour for background matching and signalling. Males of Gasterosteus aculeatus develop ornamental blue eyes and a red jaw during the reproductive season, colours that are further enhanced during courtship. Here, we investigated the effects of different hormones on physiological colour changes in the eyes and jaws of male and female sticklebacks in vitro. In an in vivo experiment, sticklebacks were injected with a receptor blocker of a pivotal hormone that controls colour change. We found in males that noradrenaline had aggregating effects on melanophore and erythrophore pigments resulting in blue eyes and a pale jaw, whereas melanocyte-concentrating hormone (MCH) and melatonin resulted in a pale jaw only. When noradrenalin was combined with melanocyte stimulating hormone (MSH) or prolactin, the jaw became red, while the eyes remained blue. In vivo injection of yohimbine, an alpha-2 adrenoreceptor blocker, resulted in dispersion of melanophore pigment in the eyes and inhibited the blue colouration. Altogether, the data suggest that noradrenalin has a pivotal role in the short-term enhancement of the ornamental colouration of male sticklebacks, potentially together with MSH or prolactin. Interestingly, we also found a sex difference in the response to MCH, prolactin and melatonin, which may result from different appearance strategies in males, versus the more cryptic females.
DOI: 10.6084/m9.figshare.5801253
title: Prevalence data for AIR cross-sectional study

description: Data from a cross-sectional study on the prevalence of anomalous information reception in general, and differences between the general population, scientists and engineers and people who are biased towards anomalous information reception.
DOI: 10.6084/m9.figshare.5801253.v1
title: Prevalence data

description: Data from a cross-sectional study on the prevalence of anomalous information reception in general, and differences between the general population, scientists and engineers and people who are biased towards anomalous information reception.
DOI: 10.6084/m9.figshare.5799378
title: Data "ENSO-driven climate variability promotes periodic major outbreaks of dengue in Venezuela"

description: The data comprises monthly data of dengue incidence and climate variables such as temperatures (mean, minimum and maximum) and precipitation values of two states from Northern Venezuela (Aragua and Carabobo).<br>1.-month: From January to December2.-year: From 2001 to 20163.-dengue_incidence: dengue incidence per 100.000 pop.4.-tmax: In Celsius (°C)5.-tmin: In Celsius (°C)6.-tmean: In Celsius (°C)7.-precipitation: In mm. <br>
DOI: 10.6084/m9.figshare.5799378.v1
title: Data "ENSO-driven climate variability promotes periodic major outbreaks of dengue in Venezuela"

description: The data comprises monthly data of dengue incidence and climate variables such as temperatures (mean, minimum and maximum) and precipitation values of two states from Northern Venezuela (Aragua and Carabobo).<br>1.-month: From January to December2.-year: From 2001 to 20163.-dengue_incidence: dengue incidence per 100.000 pop.4.-tmax: In Celsius (°C)5.-tmin: In Celsius (°C)6.-tmean: In Celsius (°C)7.-precipitation: In mm. <br>
DOI: 10.6084/m9.figshare.5799342
title: Google sheets: 'Enhanced' OA publications data and figures

description: Public google spreadsheet holds the results of a query for an 'enhanced open access publications datset. The tabs show further derivations from this raw data that underpin the visualisations within the paper 'Exploring researcher engagement with open access at Brunel University London using emergent open science infrastructure':<br>https://docs.google.com/spreadsheets/d/1mBnLo_QCKdlFlLwTufINySdN2Euy_CHPBp2GGslaHuQ/edit?usp=sharing<br><br>Obscured or ommited from raw article level dataset - available on request:- Internal record IDs from Symplectic- Journal ISSNs- Citation figures at article level obscured, because some of this data is proprietary. The highest citation figure between Scopus, WoS and Europe PMC is collected at the article level. The average citation was used within the paper and is retained in tab 4.
DOI: 10.6084/m9.figshare.5799342.v3
title: Google sheets: 'Enhanced' OA publications data and figures

description: Public google spreadsheet holds the results of a query for an 'enhanced open access publications datset. The tabs show further derivations from this raw data that underpin the visualisations within the paper 'Exploring researcher engagement with open access at Brunel University London using emergent open science infrastructure':<br>https://docs.google.com/spreadsheets/d/1mBnLo_QCKdlFlLwTufINySdN2Euy_CHPBp2GGslaHuQ/edit?usp=sharing<br><br>Obscured or ommited from raw article level dataset - available on request:- Internal record IDs from Symplectic- Journal ISSNs- Citation figures at article level obscured, because some of this data is proprietary. The highest citation figure between Scopus, WoS and Europe PMC is collected at the article level. The average citation was used within the paper and is retained in tab 4.
DOI: 10.6084/m9.figshare.5799342.v2
title: Google sheets: 'Enhanced' OA publications data and figures

description: <b>THE DATA LINK IS CURRENT DISABLED UNTIL SUBMISSION AND PUBLICATION BY PREPRINT</b><br>Public google spreadsheet holds the results of a query for an 'enhanced open access publications datset. The tabs show further derivations from this raw data that underpin the visualisations within the paper 'Exploring researcher engagement with open access at Brunel University London using emergent open science infrastructure': https://docs.google.com/spreadsheets/d/1mBnLo_QCKdlFlLwTufINySdN2Euy_CHPBp2GGslaHuQ/edit?usp=sharing<br><br>Obscured or ommited from raw article level dataset - available on request:- Internal record IDs from Symplectic- Journal ISSNs- Citation figures at article level obscured, because some of this data is proprietary. The highest citation figure between Scopus, WoS and Europe PMC is collected at the article level. The average citation was used within the paper and is retained in tab 4.
DOI: 10.6084/m9.figshare.5799339
title: Sherpa REF: SQL query and data sample

description: Collection of data and SQL elements from Sherpa REF (data licensed under CC-BY-NC) underpinning the 'Exploring researcher engagement with open access at Brunel University London using emergent open science infrastructure' study
DOI: 10.6084/m9.figshare.5799339.v1
title: Sherpa REF: SQL query and data sample

description: Collection of data and SQL elements from Sherpa REF (data licensed under CC-BY-NC) underpinning the 'Exploring researcher engagement with open access at Brunel University London using emergent open science infrastructure' study
DOI: 10.6084/m9.figshare.5799336
title: CORE: SQL query and data sample

description: Collection of data and SQL elements underpinning the 'Exploring researcher engagement with open access at Brunel University London using emergent open science infrastructure' study
DOI: 10.6084/m9.figshare.5799336.v1
title: CORE: SQL query and data sample

description: Collection of data and SQL elements underpinning the 'Exploring researcher engagement with open access at Brunel University London using emergent open science infrastructure' study
DOI: 10.6084/m9.figshare.5799336.v2
title: CORE: SQL query and data sample

description: Collection of data and SQL elements underpinning the 'Exploring researcher engagement with open access at Brunel University London using emergent open science infrastructure' study
DOI: 10.6084/m9.figshare.5799303
title: Unpaywall: location SQL query and data sample

description: Collection of data and SQL elements underpinning the 'Exploring researcher engagement with open access at Brunel University London using emergent open science infrastructure' study
DOI: 10.6084/m9.figshare.5799303.v2
title: Unpaywall: location SQL query and data sample

description: Collection of data and SQL elements underpinning the 'Exploring researcher engagement with open access at Brunel University London using emergent open science infrastructure' study
DOI: 10.6084/m9.figshare.5799303.v1
title: Unpaywall: location SQL query and data sample

description: Collection of data and SQL elements underpinning the 'Exploring researcher engagement with open access at Brunel University London using emergent open science infrastructure' study
DOI: 10.6084/m9.figshare.5799222
title: Elements: SQL query and data sample

description: Collection of data and SQL elements underpinning the 'Exploring researcher engagement with open access at Brunel University London using emergent open science infrastructure' study<br>1) CDM highlighting Elements<br>2) Elements query normalises data for single system publication records and selects fields relevant for open access compliance data<br>3) Query result. Comprisiing 5803 outputs; journal articles or conference proceedings accepted, but not published<br>obscured fields:<br>- Internal System ID fields; ID, apc_jiscID, Bura 'not Live' fields- Accepted outputs, not yet published and not yet made Live on BURA system (metadata/file release)<br>- Business fields not relevant to paper; apc_admin, apc_request, apc_jiscID, apc_corrAuthor, DataAccessS- Proprietary article level citations; citeWos, citeSco, citePubM- acceptance_yrwk. Acceptance year retained, but yrwk deemed too specific for general public release.<br>All other released data is in the public domain.
DOI: 10.6084/m9.figshare.5799213
title: PET-adapted therapy for advanced Hodgkin lymphoma – systematic review

description: <b>Introduction:</b> Positron emission tomography-computed tomography (PET-CT) performed after two chemotherapy cycles (PET-2) has become an accepted prognostic tool in Hodgkin lymphoma (HL). We evaluated the effect of PET-adapted strategy on outcome in advanced stage HL. <b>Methods:</b> In August 2017, we searched electronic databases, conference proceedings and ongoing trials. We included all studies in which treatment modification for advanced HL was performed based on the results of the interim PET scan. The primary analysis included randomized controlled trials (RCTs). Outcomes were progression-free survival (PFS) and overall survival (OS). <b>Results:</b> We identified 13 studies (4 RCTs, 7 phase II and 2 retrospective studies), conducted between 1999 and 2014, including 6856 patients. Of the four RCTS: one used therapy escalation, one did de-escalation and two trials performed both. Outcomes were assessed at different time point between 2 and 5 years. Three RCTs for de-escalating therapy, obtained similar outcomes despite reducing therapy, with a 2-year PFS of 88–92% (6 escalated BEACOPP (EB) vs. 4 ABVD cycles), a 5-year PFS of 91–92% (6/8 EB vs. 4 EB cycles) and a 5-year PFS of 80–82% (6 ABVD vs. omitting bleomycin after two successful ABVD cycles). Two RCTs implemented escalation. The randomization was between adding rituximab or not. In both trials, it did not affect outcome, with a 4-year PFS of 68–69% (addition of rituximab to BEACOPP after 2 ABVD cycles) and 5-year PFS of 88–90% (addition of rituximab to EB after 2 EB cycles). Performing true randomization between PET-adapted and a standard ABVD control arm was not feasible, given historical data. <b>Conclusions:</b> This systematic review of PET-adapted therapy, mainly based on RCTs, suggests that a change to the treatment paradigm is appropriate in advanced HL.
DOI: 10.6084/m9.figshare.5799213.v1
title: PET-adapted therapy for advanced Hodgkin lymphoma – systematic review

description: <b>Introduction:</b> Positron emission tomography-computed tomography (PET-CT) performed after two chemotherapy cycles (PET-2) has become an accepted prognostic tool in Hodgkin lymphoma (HL). We evaluated the effect of PET-adapted strategy on outcome in advanced stage HL. <b>Methods:</b> In August 2017, we searched electronic databases, conference proceedings and ongoing trials. We included all studies in which treatment modification for advanced HL was performed based on the results of the interim PET scan. The primary analysis included randomized controlled trials (RCTs). Outcomes were progression-free survival (PFS) and overall survival (OS). <b>Results:</b> We identified 13 studies (4 RCTs, 7 phase II and 2 retrospective studies), conducted between 1999 and 2014, including 6856 patients. Of the four RCTS: one used therapy escalation, one did de-escalation and two trials performed both. Outcomes were assessed at different time point between 2 and 5 years. Three RCTs for de-escalating therapy, obtained similar outcomes despite reducing therapy, with a 2-year PFS of 88–92% (6 escalated BEACOPP (EB) vs. 4 ABVD cycles), a 5-year PFS of 91–92% (6/8 EB vs. 4 EB cycles) and a 5-year PFS of 80–82% (6 ABVD vs. omitting bleomycin after two successful ABVD cycles). Two RCTs implemented escalation. The randomization was between adding rituximab or not. In both trials, it did not affect outcome, with a 4-year PFS of 68–69% (addition of rituximab to BEACOPP after 2 ABVD cycles) and 5-year PFS of 88–90% (addition of rituximab to EB after 2 EB cycles). Performing true randomization between PET-adapted and a standard ABVD control arm was not feasible, given historical data. <b>Conclusions:</b> This systematic review of PET-adapted therapy, mainly based on RCTs, suggests that a change to the treatment paradigm is appropriate in advanced HL.
DOI: 10.6084/m9.figshare.5799189
title: Gerhana Bulan di Indonesia 2018 -2020

description: infographic book for lunar eclipse in Indonesia from 2018 - 2020.<br>
DOI: 10.6084/m9.figshare.5799189.v3
title: Gerhana Bulan di Indonesia 2018 -2020

description: infographic book for lunar eclipse in Indonesia from 2018 - 2020.<br>
DOI: 10.6084/m9.figshare.5799189.v2
title: Gerhana Bulan di Indonesia 2018 -2020

description: infographic for lunar eclipse in Indonesia from 2018 - 2020
DOI: 10.6084/m9.figshare.5799132.v1
title: Bulk viscosities of molecular fluids

description: Input data files and results files to accompany " Bulk viscosities of molecular fluids" by F. Jaeger et al. , submitted to J. Chem. Phys. ( 2018 )
DOI: 10.6084/m9.figshare.5799123
title: Effects of Telestroke on Thrombolysis Times and Outcomes: A Meta-analysis

description: <b>Objective</b>: Telestroke systems are tools, used to provide an advanced stroke care in regions without sufficient neurologic services. We performed this meta-analysis to assess the effects of telemedicine on treatment times and clinical outcomes of acute stroke care. <b>Methods:</b> A literature search of PubMed, SCOPUS, and Cochrane CENTRAL was conducted for original studies investigating telemedicine applications in acute stroke care. Dichotomous data on treatment outcomes were pooled as odds ratios (ORs), while continuous data on thrombolysis times were pooled as mean differences (MDs) with 95% confidence interval (CI), using RevMan software (version 5.3). <b>Results</b>: Pooling data from 26 studies (6605 thrombolysed patients) showed no significant differences between the telestroke and control groups in terms of in-hospital mortality (OR = 1.21, 95% CI [0.98, 1.49]), 90-day mortality (OR = 1.08, 95% CI [0.85, 1.37]), symptomatic intracranial hemorrhage (sICH) (OR = 1.10, 95% CI [0.79, 1.53]), and favorable clinical outcome at discharge (OR = 1.03, 95% CI [0.69, 1.53]) and 90 days later (OR = 0.99, 95% CI [0.82, 1.18]). The onset-to-door (OTD) duration (MD = −10.4 minutes, 95% CI [−14.79, −.01]) and length of hospital stay (MD = −0.55 days, 95% CI [−1.02, −0.07]) were significantly shorter in the telestroke group, compared to the control group. Although the overall effect estimate (under the fixed-effect model) showed a significant decrease in the onset-to-treatment (OTT) duration in the telestroke group (MD = −5.83 minutes, 95% CI [−8.57, −3.09]), employing the random-effects model for between-study heterogeneity abolished this significance (MD = −5.90 minutes, 95% CI [−13.23, 1.42]). <b>Conclusion</b>: Telestroke significantly reduced OTD and hospital stay durations in stroke patients without increasing the risk of mortality or sICH. Therefore, telemedicine can improve stroke care in regional areas with minor experience in thrombolysis. Further randomized controlled trials are needed to assess the benefits of telestroke systems, especially in terms of cost-effectiveness and quality of life outcomes.